NH
Neuberger High Yield Strategies Fund Inc.
NHS · AMEX
$5.93 -0.17% (-$0.01)
1M -2.47%
Market Cap $186.6M
P/E Ratio 9.23x
Div. Yield 18.27%
ROE 8.24%
Bulios Fair Price
$6.29
6.1% upside
Current Price
$5.93
Undervalued Fair Value Overvalued
According to Bulios Fair Price, NHS is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
83 /100
Cheap P/B 0.80x
P/E 9.23x
P/S 6.98x
Growth
100 /100
Growing Book val. growth 11.50%
Rev. growth 41.00%
FCF growth N/A
Profitability
100 /100
Strong Op. margin 95.14%
Net margin 75.67%
FCF margin N/A
Quality
72 /100
Excellent Asset turnover 0.08x
ROE 8.24%
ROA 5.95%
Debt
0 /100
High Current ratio 0.00x
Net debt/EBITDA N/A
Debt/Equity N/A
Stability
31 /100
Unstable EPS volatility 525.14%
Beta 0.76x
Profitable years 3
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NHS
Online
Sector
Financial Services
Industry
Asset Management
CEO
Joseph Vincent Amato
Employees
-
Headquarters
New York City
Upcoming events
15 SEP
Ex-Dividend
Ex-dividend date
30 SEP
Dividend Payment
Payment date